Company profile
Trees Corporation
OTC: CANN · Healthcare · Drug Manufacturers - Specialty & Generic
#562 of 1,418 Healthcare companies by revenue73rd-percentile growth
EA Score
——FH —DQ 52GM —SS 54
v0.1 · 25/100 weight · pillars only
↑ 3-yr revenue growth, disclosure history · ↓ return on equity, filing timeliness
Methodology →Revenue TTM
$13.7M
Rev growth YoY (TTM)
-24.7%
Net income (FY)
-$7.1M
Employees
91
as of 2026-08-25
Market cap
$2.4M
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$18.1M$18.1M2023
Net income-$7.1M-$7.1M2023
Operating income-$4.0M-$4.0M2023
Total assets$23.2M$23.2M2023
Liabilities$23.1M$23.1M2023
Equity$148.2k$148.2k2023
Revenue trend
FY2016 – FY2023 · USD
FY16
FY17
FY18
FY19
FY21
FY21
FY22
FY23
Revenue by segment
Filed disclosures · FY2023
By product
Retail100%
By geography
Not disclosed.
The read
What is Trees Corporation’s revenue?
Trees Corporation booked $18.1M in FY2023 revenue, growing 35% year over year — faster than most Healthcare companies we track, at a -39.0% net margin.
Peers · Healthcare
Fuse Medical, Inc.——PD-Rx Pharmaceuticals, Inc.70BAvicanna Inc.55CMarpai, Inc.34DResponse Genetics, Inc——ManifestSeven Holdings Corporation——Neighbors
Jefferson →Key facts
CEOAdam L. Hershey
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersLakewood, CO
ExchangeOTC: CANN
Employees91
IPO date2012-03-01
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.